Inactive
Partial Small Business Set-Aside (FAR 19.5)
Notice ID:20-005652
INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The Nat...
INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH), Clinical Center (CC), Office of Purchasing and Contracts (OPC) on behalf of the Department of Critical Care Medicine Department, Clinical Center (CC) at the National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to: Bio-Rad 4000 Alfred Nobel, Dr. Hercules, CA 94547-1803 UNITED STATES NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 811219 with a Size Standard $20,500 million. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2005-97, January 24, 2018. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($150,000). STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION 1. Title: Service Support agreement covering the Digital PCR System that performs translational research studies for routine patient care testing of Clinical Center patients. 2. Background Information: The Critical Care Medicine Department conducts active research programs in bedside clinical investigation, research in animal models, and molecular biology. Full-time research activities commence at the beginning of the second year of the fellowship for fellows interested in the critical care subspecialty alone. For those interested in dual board eligibility, their second-year program is individually designed and consists of clinical rotations required for board eligibility in the particular subspecialties. After completion of second subspecialty training, full-time research activities commence. Major topics of research interest within the Department include: The immunopathogenesis of septic shock Studies of immune cellular function in respiratory distress syndrome, asthma, and other forms of severe pulmonary disease Biomarkers and novel therapies in pulmonary arterial hypertension Biomarkers of acute cellular rejection in heart transplantation Diagnosis and treatment of opportunistic infections Studies of immune cellular function and therapy of AIDS Pathogenesis and treatment of anthrax Emerging infectious diseases Biology and clinical effects of nitric oxide acute lung injury pulmonary arterial hypertension role as transcription regulatory factor Functional genomics of critical illness human acute inflammation animal model of septic shock and multiple organ failure pulmonary arterial hypertension solid organ transplantation Emerging Infectious 3. Purpose or Objective: The purpose of this correspondence is to request a multiyear Purchase Order (PO) for a service Maintenance contract on the PCR Digital System that performs translational research evaluating the pathogenesis and treatment of high-consequence respiratory viral pathogens, inflammation, pulmonary hypertension, and samples from our emergent diseases research for protocol studies. * Comprehensive and all-inclusive (Labor, Parts) * Travel included for all On-site coverage plans * Unlimited repairs during the contract period * Highest Service Dispatching Priority * Maximize instrument performance and up-time - Increased Productivity * Complete peace of mind / Extended Instrument Life / Predictable cost * Eligible for contract renewal at the standard contract rate * Mail-in coverage also includes all shipping costs and loaner instrument (upon availability) 4. Period of Performance: BASE of One (1) Year with 2 additional Option Periods of Two (2) Year each. CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME) DETERMINATION The intended sole source is the only known source to meet the technical needs of the scientific equipment/supplies. The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted as prescribed in FAR Part 10-Market Research. CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by March 02, 2020, 12:00 PM Eastern time and must reference solicitation number 20-005652. Responses may be submitted electronically to Priscilla Abalos, Contracting Specialist at Priscilla.abalos@nih.gov. Fax responses will not be accepted. "All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency."
